Aro Biotherapeutics
Aro Biotherapeutics is focused on the development of a new protein drug platform called Centyrins, designed to achieve better efficacy and safety profiles for patients with cancer and other serious diseases. Centyrins are small, non-antibody protein scaffolds that can be expressed as multi-specifics with novel therapeutic mechanisms of action. Centyrins are also ideal for the targeted delivery of complex drug payloads, including nucleic acids.
Domain
arobiotx.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$41.5M
Founded
2016
Tech Stack (15 technologies)
Frequently Asked Questions
What technologies does Aro Biotherapeutics use?+
Aro Biotherapeutics uses 15 technologies including Google Analytics, Google Analytics Enhanced eCommerce, Google Tag Manager.
What industry is Aro Biotherapeutics in?+
Aro Biotherapeutics operates in the Biotechnology industry.
Where is Aro Biotherapeutics based?+
Aro Biotherapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026